Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.65% 0.05% 517.96M 3946.63
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0.83% 27.73% 59.12M Upgrade

Basic Info

Investment Strategy
XHC seeks to provide long-term capital growth by replicating, to the extent possible, the performance of the S&P Global 1200 Health Care Canadian Dollar Hedged Index, net of expenses. Under normal market conditions, XHC will primarily invest in securities of one or more iShares ETFs and/or equity securities of international issuers participating in the healthcare sector.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Category Index Morningstar Gbl Mkts GR CAD
Prospectus Objective --
Fund Owner Firm Name iShares
Prospectus Benchmark Index
S&P Gbl 1200 HealthCare Hdg NR CAD 100.0%
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%
Manager Tenure
Not Disclosed 10.56 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 22
59.12M
-158.95M Category Low
1.324B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of October 31, 2021

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of November 29, 2021. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2014
2015
2016
2017
2018
2019
2020
YTD
21.91%
8.29%
-5.33%
16.84%
2.19%
22.47%
8.73%
14.95%
12.27%
-7.76%
21.36%
9.78%
-7.58%
21.93%
5.56%
26.71%
34.72%
6.77%
-5.04%
25.34%
-2.86%
26.00%
21.65%
11.10%
--
--
--
--
-2.09%
25.00%
7.62%
14.19%
7.07%
0.07%
13.27%
20.24%
-13.95%
26.41%
4.64%
17.07%
--
-21.97%
21.49%
-13.03%
-17.85%
-23.09%
-12.96%
34.55%
As of November 29, 2021.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (11-30-21) 0.83%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 26.80
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of November 26, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of November 26, 2021

Asset Allocation

As of November 26, 2021.
Type % Net % Long % Short
Cash -2.19% Upgrade Upgrade
Stock 102.2% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Johnson & Johnson 6.01% 157.44 -1.45%
UnitedHealth Group Inc 5.95% 448.40 -0.80%
Pfizer Inc 4.34% 53.62 2.33%
Roche Holding AG
3.91% -- --
Thermo Fisher Scientific Inc 3.60% 640.61 -1.26%
Abbott Laboratories 3.20% 127.37 -0.52%
Eli Lilly and Co 2.96% 249.79 -1.98%
AbbVie Inc 2.95% 115.65 -1.06%
Danaher Corp 2.95% 326.56 0.01%
Merck & Co Inc 2.88% 74.25 -0.85%

News

Headline
Wire
Time (ET)
No Data Available

Basic Info

Investment Strategy
XHC seeks to provide long-term capital growth by replicating, to the extent possible, the performance of the S&P Global 1200 Health Care Canadian Dollar Hedged Index, net of expenses. Under normal market conditions, XHC will primarily invest in securities of one or more iShares ETFs and/or equity securities of international issuers participating in the healthcare sector.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Category Index Morningstar Gbl Mkts GR CAD
Prospectus Objective --
Fund Owner Firm Name iShares
Prospectus Benchmark Index
S&P Gbl 1200 HealthCare Hdg NR CAD 100.0%
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%
Manager Tenure
Not Disclosed 10.56 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (11-30-21) 0.83%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 26.80
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of November 26, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of November 26, 2021

Fund Details

Key Dates
Inception Date 4/12/2011
Last Annual Report Date 12/31/2020
Last Prospectus Date 6/25/2021
Attributes
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds Yes
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

News

Headline
Wire
Time (ET)
No Data Available